Category Archives: Coronary Heart Diseases

We are creatures of habit. Our upbringing and societal influences affect our attitudes and behaviour. How our parents and friends behave has a profound influence on our lifestyles. Continue reading →

September 08, 2020 13:02 ET | Source: Reports and Data New York, Sept. Continue reading →

Report Description A recent market intelligence report that is published by Data Insights Partner on the global Heart Valve market makes an offering of in-depth analysis of segments and sub-segments in the regional and international Heart Valve market. The research also emphasizes on the impact of restraints, drivers, and macro indicators on the regional and global Heart Valve market over the short as well as long period of time. A detailed presentation of forecast, trends, and dollar values of global Heart Valve market is offered Continue reading →

Many grew up following the guidelines of the food pyramid. The guide depicted the optimal number of servings of different food groups the average person should consume to be healthy. Continue reading →

September 08, 2020 19:00 ET | Source: Reports and Data New York, Sept. 08, 2020 (GLOBE NEWSWIRE) -- The globalBiopreservation Market is forecast to reach USD 5.63 Billion by 2027, according to a new report by Reports and Data. Continue reading →

Global Cardiopulmonary Disease Diagnostics and Treatment Marketsize was valued at US$ XX Mn. in 2019 and the total revenue is expected to grow at 6.7% from 2019 to 2027, reaching nearly US$ XX Mn Continue reading →

Bengaluru: MedGenome Lab has conducted a first-ever study on Indian population that validates a novel CAD-PRS (coronary artery disease-genome-wide polygenic risk score) to precisely predict the risk of developing a coronary artery disease/myocardial infarction (MI) using a persons genetic makeup. MedGenome collaborated with researchers from Broad Institute of MIT and Harvard; Massachusetts General Hospital, Boston; Narayana Health, Bangalore; Eternal Hospital, Jaipur; Madras Medical Mission, Chennai; KMCH, Coimbatore and a few other institutes to conduct this first-ever research capturing the PRS of disease for South Asia populations and its findings are now published in the Journal of the American College of Cardiology (JACC) Continue reading →

Rafiq Somani, area vice president, India and South Asia Pacific, Ansys explains how cardiac device engineering helps understand the behaviour of new devices and providing insight into how cardiovascular devices behave within human bodies despite their variability Cardiovascular diseases or CVDs are a group ofailments of the heart and blood vessels that include coronary heart disease, cerebrovascular disease, rheumatic heart disease and other conditions. CVDs arethe leading cause of death in the world and it takes an estimated17.9 million lives annually Continue reading →

Amarin Corporation's (AMRN) flagship product, Vascepa, is not an antiviral, steroid, antibody, or vaccine, but investors need to be aware of its potential to be a COVID-19 therapeutic. Vascepa (icosapent ethyl) is an FDA approved as an adjunct to maximally tolerated statin therapy to diminish the risk of cardiovascular events in certain adults with high triglyceride levels of 150 mg/dc or higher and other cardiovascular risk factors and to reduce severely elevated levels of triglycerides of 500 mg/dl or higher. Continue reading →

Global Cardiovascular Device Market was valued US$ XX Bn. in 2019 and is expected to reach US$ XX Bn. by 2027, at a CAGR of 6.8% during a forecast period Continue reading →